Literature DB >> 26155849

Epidemiology of candidaemia in a tertiary care university hospital: 10-year experience with 381 candidaemia episodes between 2001 and 2010.

Sehnaz Alp1, Sevtap Arikan-Akdagli2, Dolunay Gulmez2, Sibel Ascioglu1, Omrum Uzun1, Murat Akova1.   

Abstract

Defining the epidemiology of and risk factors for candidaemia is necessary to guide empirical treatment. The objectives of this study were to determine the ranking of Candida among positive blood cultures, to define the epidemiology of candidaemia and to investigate patient characteristics and their relationship with C. albicans vs. non-albicans Candida (NAC) candidaemia. Candidaemia episodes between January 2001 and December 2010 were evaluated retrospectively. Patient characteristics were compared across Candida species. Candida ranked as the fifth most frequently isolated pathogen. Among 381 candidaemia episodes, 58.3% were due to C. albicans, followed by C. parapsilosis (15.2%), C. tropicalis (13.4%) and C. glabrata (6.8%). No statistically significant difference was observed in the distribution of C. albicans vs. NAC (P = 0.432). Patients with NAC had significantly higher rates of haematological disorders (P < 0.001) and neutropenia (P = 0.003), and were older (P = 0.024) than patients with C. albicans, whereas patients with urinary catheters had higher rates of C. albicans (P = 0.007). On species basis, C. tropicalis was more frequently isolated from patients with haematological disorders (P < 0.001) and neutropenia (P = 0.008). Patients with urinary catheters were less likely to have C. parapsilosis (P = 0.043). C. glabrata was most prevalent among patients with solid organ tumours (P = 0.038), but not evident in patients with haematological disorders. Local epidemiological features and risk factors may have important implications for the management of candidaemia.
© 2015 Blackwell Verlag GmbH.

Entities:  

Keywords:  Candida albicans; Candidaemia; epidemiology; non-albicans Candida

Mesh:

Year:  2015        PMID: 26155849     DOI: 10.1111/myc.12349

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  8 in total

1.  Change in species distribution and antifungal susceptibility of candidemias in an intensive care unit of a university hospital (10-year experience).

Authors:  Bilgul Mete; Esra Yerlikaya Zerdali; Gokhan Aygun; Nese Saltoglu; Ilker Inanc Balkan; Ridvan Karaali; Sibel Yildiz Kaya; Berna Karaismailoglu; Abdurrahman Kaya; Seval Urkmez; Gunay Can; Fehmi Tabak; Recep Ozturk
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-09-15       Impact factor: 3.267

2.  Mortality-associated factors of candidemia: a multi-center prospective cohort in Turkey.

Authors:  Murat Kutlu; Selda Sayın-Kutlu; Sema Alp-Çavuş; Şerife Barçın Öztürk; Meltem Taşbakan; Betil Özhak; Onur Kaya; Oya Eren Kutsoylu; Şebnem Şenol-Akar; Özge Turhan; Gülşen Mermut; Bülent Ertuğrul; Hüsnü Pullukcu; Çiğdem Banu Çetin; Vildan Avkan-Oğuz; Nur Yapar; Dilek Yeşim-Metin; Çağrı Ergin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-01-27       Impact factor: 3.267

3.  Retrospective evaluation of candidemic patients among general surgery department in a tertiary care university hospital.

Authors:  Uğur Önal; Dilek Yeşim Metin; Can Karaca; Süleyha Hilmioğlu Polat; Sinan Ersin; Meltem Işıkgöz Taşbakan
Journal:  Turk J Surg       Date:  2019-09-23

4.  Epidemiology of Blood Stream Infection due to Candida Species in a Tertiary Care Hospital in Japan over 12 Years: Importance of Peripheral Line-Associated Candidemia.

Authors:  Masahiro Ishikane; Kayoko Hayakawa; Satoshi Kutsuna; Nozomi Takeshita; Norio Ohmagari
Journal:  PLoS One       Date:  2016-10-31       Impact factor: 3.240

5.  Population-Based Active Surveillance for Culture-Confirmed Candidemia - Four Sites, United States, 2012-2016.

Authors:  Mitsuru Toda; Sabrina R Williams; Elizabeth L Berkow; Monica M Farley; Lee H Harrison; Lindsay Bonner; Kaytlynn M Marceaux; Rosemary Hollick; Alexia Y Zhang; William Schaffner; Shawn R Lockhart; Brendan R Jackson; Snigdha Vallabhaneni
Journal:  MMWR Surveill Summ       Date:  2019-09-27

6.  Epidemiology, risk factors and outcomes of Candida albicans vs. non-albicans candidaemia in adult patients in Northeast China.

Authors:  Wei Zhang; Xingpeng Song; Hao Wu; Rui Zheng
Journal:  Epidemiol Infect       Date:  2019-09-25       Impact factor: 2.451

Review 7.  Continuing Shifts in Epidemiology and Antifungal Susceptibility Highlight the Need for Improved Disease Management of Invasive Candidiasis.

Authors:  Ben Y Parslow; Christopher R Thornton
Journal:  Microorganisms       Date:  2022-06-13

8.  Evaluation of candidemia in epidemiology and risk factors among cancer patients in a cancer center of China: an 8-year case-control study.

Authors:  Ding Li; Rui Xia; Qing Zhang; Changsen Bai; Zheng Li; Peng Zhang
Journal:  BMC Infect Dis       Date:  2017-08-03       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.